153 related articles for article (PubMed ID: 22740881)
21. Cytotoxic Effects of Some Flavonoids and Imatinib on the K562 Chronic Myeloid Leukemia Cell Line: Data Analysis Using the Combination Index Method.
Danışman Kalındemirtaş F; Birman H; Candöken E; Bilgiş Gazioğlu S; Melikoğlu G; Kuruca S
Balkan Med J; 2019 Feb; 36(2):96-105. PubMed ID: 30396879
[TBL] [Abstract][Full Text] [Related]
22. The novel pyrrolo-1,5-benzoxazepine, PBOX-15, synergistically enhances the apoptotic efficacy of imatinib in gastrointestinal stromal tumours; suggested mechanism of action of PBOX-15.
Kinsella P; Greene LM; Bright SA; Pollock JK; Butini S; Campiani G; Bauer S; Williams DC; Zisterer DM
Invest New Drugs; 2016 Apr; 34(2):159-67. PubMed ID: 26885657
[TBL] [Abstract][Full Text] [Related]
23. The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.
Gatto S; Scappini B; Pham L; Onida F; Milella M; Ball G; Ricci C; Divoky V; Verstovsek S; Kantarjian HM; Keating MJ; Cortes-Franco JE; Beran M
Haematologica; 2003 Aug; 88(8):853-63. PubMed ID: 12935973
[TBL] [Abstract][Full Text] [Related]
24. Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells.
Wesierska-Gadek J; Schmitz ML; Ranftler C
J Cell Biochem; 2007 Mar; 100(4):865-74. PubMed ID: 17203463
[TBL] [Abstract][Full Text] [Related]
25. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J
J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201
[TBL] [Abstract][Full Text] [Related]
26. Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB.
Erdogan S; Turkekul K; Dibirdik I; Doganlar ZB; Doganlar O; Bilir A
Invest New Drugs; 2020 Apr; 38(2):246-263. PubMed ID: 30993586
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic effect of 6-Shogaol in Imatinib sensitive and resistant K562 cells.
Ozkan T; Hekmatshoar Y; Pamuk H; Ozcan M; Yaman G; Yagiz GC; Akdemir C; Sunguroglu A
Mol Biol Rep; 2021 Feb; 48(2):1625-1631. PubMed ID: 33515349
[TBL] [Abstract][Full Text] [Related]
28. [Protective Effect of Shenfu Injection on Postresuscitation Lung Injury in a Porcine Model of As- physia-induced Cardiac Arrest].
Yang J; Li CS; Wu CJ; Hang CC
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Aug; 36(8):967-974. PubMed ID: 30640993
[TBL] [Abstract][Full Text] [Related]
29. Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells.
Dong Y; Han Q; Zou Y; Deng Z; Lu X; Wang X; Zhang W; Jin H; Su J; Jiang T; Ren H
Mol Cell Biochem; 2012 Nov; 370(1-2):89-102. PubMed ID: 22829019
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic hypothermia reduced brain damage on rats after cardiopulmonary resuscitation by activating III-type PI3K pathway to increase autophagy].
Xiao Y; Zhao X; Zhu J; Zou Q; Liu L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan; 31(1):55-60. PubMed ID: 30707870
[TBL] [Abstract][Full Text] [Related]
31. Roscovitine differentially affects asynchronously growing and synchronized human MCF-7 breast cancer cells.
Maurer M; Komina O; Wesierska-Gadek J
Ann N Y Acad Sci; 2009 Aug; 1171():250-6. PubMed ID: 19723062
[TBL] [Abstract][Full Text] [Related]
32. Predicting Effectiveness of Imatinib Mesylate in Tumors Expressing Platelet-Derived Growth Factors (PDGF-AA, PDGF-BB), Stem Cell Factor Ligands and Their Respective Receptors (PDGFR-α, PDGFR-β, and c-kit).
Moawad EY
J Gastrointest Cancer; 2015 Sep; 46(3):272-83. PubMed ID: 25985771
[TBL] [Abstract][Full Text] [Related]
33. Reconstitution of human MCF-7 breast cancer cells with caspase-3 does not sensitize them to action of CDK inhibitors.
Węsierska-Gądek J; Hackl S; Zulehner N; Maurer M; Komina O
J Cell Biochem; 2011 Jan; 112(1):273-88. PubMed ID: 21080333
[TBL] [Abstract][Full Text] [Related]
34. A polymethoxyflavone from Laggera pterodonta induces apoptosis in imatinib-resistant K562R cells via activation of the intrinsic apoptosis pathway.
Cao C; Liu B; Zeng C; Lu Y; Chen S; Yang L; Li B; Li Y; Li Y
Cancer Cell Int; 2014; 14(1):137. PubMed ID: 25530716
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis is involved in the mechanism of postresuscitation myocardial dysfunction in a porcine model of cardiac arrest.
Gu W; Li CS; Yin WP; Guo ZJ; Hou XM; Zhang D
Am J Emerg Med; 2012 Nov; 30(9):2039-45. PubMed ID: 22867832
[TBL] [Abstract][Full Text] [Related]
36. Combination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells.
Motawi TM; Sadik NA; Fahim SA; Shouman SA
Chem Biol Interact; 2015 May; 233():147-56. PubMed ID: 25863232
[TBL] [Abstract][Full Text] [Related]
37. Cyclin-dependent kinase inhibitors, roscovitine and purvalanol, induce apoptosis and autophagy related to unfolded protein response in HeLa cervical cancer cells.
Ozfiliz-Kilbas P; Sarikaya B; Obakan-Yerlikaya P; Coker-Gurkan A; Arisan ED; Temizci B; Palavan-Unsal N
Mol Biol Rep; 2018 Oct; 45(5):815-828. PubMed ID: 29978381
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of farnesyl protein transferase sensitizes human MCF-7 breast cancer cells to roscovitine-mediated cell cycle arrest.
Wesierska-Gadek J; Maurer M; Schmid G
J Cell Biochem; 2007 Oct; 102(3):736-47. PubMed ID: 17415788
[TBL] [Abstract][Full Text] [Related]
39. The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1.
Pan J; Quintás-Cardama A; Manshouri T; Giles FJ; Lamb P; Tefferi A; Cortes J; Kantarjian H; Verstovsek S
Leukemia; 2007 Jul; 21(7):1395-404. PubMed ID: 17495975
[TBL] [Abstract][Full Text] [Related]
40. Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study.
Kolodziej M; Goetz C; Di Fazio P; Montalbano R; Ocker M; Strik H; Quint K
Oncol Rep; 2015 Sep; 34(3):1549-56. PubMed ID: 26151768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]